P
PharmaBioSource, Inc.
For PharmaBioSource, Inc.
Is this your company?
Edverise AI compiled this profile from public information so buyers could find you. Claim it to edit every field, add your portfolio and respond to reviews.
Claim & verify for free
Manage the listing yourself. Verify by work email or company domain to earn the verified badge.
Suggest an edit
Not ready to claim? Send a correction and our team will review and update verified factual errors.
Overview
2 - 9
Employees
2020
Year Founded
ABOUT PHARMABIOSOURCE, INC.
Consulting
Our team consists of engineers, scientists, manufacturing professionals, and finance experts who possess a wealth of experience in the pharmaceutical sector. We develop comprehensive and innovative solutions that facilitate successful outcomes in life science transactions. Thanks to our industry knowledge, extensive contacts, global reach, and demonstrated success, we are a highly valued resource for companies, facilities, and therapeutic asset deals in the life sciences.
Languages Spoken
English
HIGHLIGHTS
2 - 9
Employees
2020
Year Founded
Services
Focus
Industries
Clients
Services Provided
40% Writing Services
40% Business Consulting Services
20% Financial Advisory & Consulting
About the Team
OUR STORY
PharmaBioSource originated over 20 years ago when founder and CEO William (Bill) Wiederseim identified a unique industry need while assisting a multinational pharmaceutical company with selling a plant. Recognizing the demand for a firm that comprehended both drug engineering and manufacturing alongside financial and accounting expertise, he assembled a team of pharmaceutical executives, engineers, scientists, and finance professionals to establish a specialized entity dedicated to managing biopharma transactions from start to finish. Since then, PharmaBioSource has evolved into a multinational organization operating across three continents, successfully facilitating over 100 transactions involving therapeutic assets and pharmaceutical facilities totaling more than $4 billion. Their longstanding commitment remains delivering expert guidance, innovative strategies, and actionable intelligence to global biopharmaceutical companies, service providers, and investors worldwide.